Chiara Porta
Novara, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Editorial: Community series in new insights into innate immune cell-based immunotherapies in cancer, volume II.
Journal: Frontiers in immunology
Published: June 03, 2026
Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives.
Journal: Cancers
Published: November 13, 2025
Targeting the antioxidant, antimicrobial and anti-inflammatory activity of non-psychotropic Cannabis sativa L.: a comparison with chemotype V.
Journal: Journal of cannabis research
Published: July 09, 2025
The Dual Role of ACE2 in IBD: Balancing SARS-CoV-2 Susceptibility and Gut Homeostasis.
Journal: Inflammatory bowel diseases
Published: June 24, 2025
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease.
Journal: Inflammatory bowel diseases
Published: December 31, 2024
The PYRIN domain is required for TLR4-mediated inflammation by PYHIN family members.
Journal: iScience
Published: September 09, 2024
Editorial: New insights into innate immune cell-based immunotherapies in cancer.
Journal: Frontiers in immunology
Published: March 15, 2024
Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy.
Journal: Frontiers in immunology
Published: July 01, 2023
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma.
Journal: Cancers
Published: February 01, 2023
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective.
Journal: Cancers
Published: December 30, 2021
Inhibition of the Histone Methyltransferase EZH2 Enhances Protumor Monocyte Recruitment in Human Mesothelioma Spheroids.
Journal: International journal of molecular sciences
Published: March 26, 2021
Last Updated: 09/26/2026